Skip to content

Evaluation of the efficacy of heated wet room endoscope combined with blinking training in the treatment of dry eyes in VDT

Evaluation of the efficacy of heated wet room endoscope combined with blinking training in the treatment of dry eyes in VDT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056492
Enrollment
Unknown
Registered
2022-02-06
Start date
2022-02-10
Completion date
Unknown
Last updated
2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Video terminal dry eye

Interventions

Group one:Wear a heated wet room mirror
Group two:Wear heated wet room glasses for 15 minutes combined with blinking training for 5 minutes

Sponsors

Ophthalmology Hospital affiliated to Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Regardless of sex, aged over 18 years old, dry eye history >= 3 months, working long hours in the office every working day, using optical display screen for more than 4 hours per day; 2. The patient has at least 2 positive subjective symptoms such as eye dryness, foreign body sensation, burning sensation, eye fatigue, red eye, blurred vision, vision fluctuation, photophobia, etc.; 3. Eye surface disease index (OSDI) > 13; 4. The rupture time of fluorescein tear film (FTBUT) was less than 5 seconds; 5. The score of sodium fluorescein staining was less than 10 points; 6. The LLT of both eyes of the patients was < 70nm; 7. They had not participated in other drug clinical trials within 2 weeks; 8. All patients voluntarily selected and accepted the heated wet room lens used in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Obvious opacity of refractive medium or recent wearing of corneal contact lenses; 2. History of internal eye surgery or ocular trauma; 3. Clinically suspected or combined with other eye diseases, such as allergic keratoconjunctivitis, corneal inflammatory diseases, glaucoma, abnormal eyelids and abnormal skin around the eyes, etc.; 4. There is a history of systemic or eye drug treatment within 3 months, which is predicted to affect the evaluators of the results of the study, such as hormones, retinoic acid, sympathetic drugs, antipsychotics, antiallergic drugs, immunosuppressants, etc.

Design outcomes

Primary

MeasureTime frame
Thickness of lipid layer of tear film;

Secondary

MeasureTime frame
Thickness of lipid layer of tear film;Conjunctival red index;

Countries

China

Contacts

Public ContactZheng Qinxiang

Ophthalmology Hospital affiliated to Wenzhou Medical University

zhengqinxiang@aliyun.com+86 13738379810

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026